What differences might we see with different combinations of drugs?

Has the eGFR #s not been shared so far because of there importance to cognitive function?

Since we know from previous trials that plaque regression was better when apabetalone was in combination with Crestor vs Lipitor, is it a strech to think that the eGFR increase will be higher with those patients on Crestor vs Lipitor in BETonMACE?

If more plaque was removed from arteries in combo with Crestor, would it be a strech to think that along with reduced inflamation would more plaques would be removed from where ever blood flows in the body including the brian? 

Will we see a greater increase(assuming we see an incrase at all) in cognitive function  in those patients in the over 70 group on Crestor vs Lipitor?

How will the SGLT2s affect the eGFRs and cognitive function?

Where is the journal write-up and will that referrence info to answer my questions?

Thursday afternoon can't get here soon enough.

tada